Positive Clinical Trial Results for Immunovaccine's DPX-0907 Published in … MarketWatch (press release) As previously announced, 73 percent of the study's immune responders generated a response following the first vaccination suggesting favorable immune induction potential for DPX-0907 and 64 percent maintained a persistent response at one month …
Continued here:
Positive Clinical Trial Results for Immunovaccine’s DPX-0907 Published in … – MarketWatch (press release)
Click here for more interesting articles
Tags: Immune support